Literature DB >> 17849184

Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence.

Stephanie A Navarro Silvera1, Thomas E Rohan.   

Abstract

Mesh：

Year:  2007        PMID： 17849184     DOI： 10.1007/s10549-007-9740-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  10 in total

1.  Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats.

Authors:  Takashi Yuri; Yen-Chang Lai; Sayaka Kanematsu; Maki Kuwata; Katsuhiko Yoshizawa; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

2.  Physical activity and risk of benign proliferative epithelial disorders of the breast, in the Women's Health Initiative.

Authors:  Rita Peila; Rowan T Chlebowski; Tarah J Ballinger; Victor Kamensky; Phyllis A Richey; Nazmus Saquib; Aladdin H Shadyab; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  Int J Epidemiol       Date:  2021-06-17       Impact factor: 9.685

3.  Mutations in the mitochondrial DNA D-loop region and breast cancer risk.

Authors:  Chuanzhong Ye; Xiao Ou Shu; Larry Pierce; Wanqing Wen; Regina Courtney; Yu-Tang Gao; Wei Zheng; Qiuyin Cai
Journal:  Breast Cancer Res Treat       Date:  2009-04-21       Impact factor: 4.872

Review 4.  Preadolescent and adolescent risk factors for benign breast disease.

Authors:  A Lindsay Frazier; Shoshana M Rosenberg
Journal:  J Adolesc Health       Date:  2013-05       Impact factor: 5.012

Review 5.  Breast cancer risk accumulation starts early: prevention must also.

Authors:  Graham A Colditz; Kari Bohlke; Catherine S Berkey
Journal:  Breast Cancer Res Treat       Date:  2014-05-13       Impact factor: 4.872

6.  Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast.

Authors:  Chelsea Catsburg; Marc J Gunter; Lesley Tinker; Rowan T Chlebowski; Michael Pollak; Howard D Strickler; Michele L Cote; David L Page; Thomas E Rohan
Journal:  J Cancer Epidemiol       Date:  2015-05-28

7.  A MOUSE MODEL OF MAMMARY HYPERPLASIA INDUCED BY ORAL HORMONE ADMINISTRATION.

Authors:  Li Sun; Dong-Hui Guo; Fei Liu; Qian Liu; Ning Jiang; Yun-Feng Sun; Li-Ping Cai; Hong-Xin Zheng
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05

8.  Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer.

Authors:  Jingmei Li; Keith Humphreys; Peh Joo Ho; Mikael Eriksson; Eva Darai-Ramqvist; Linda Sofie Lindström; Per Hall; Kamila Czene
Journal:  JNCI Cancer Spectr       Date:  2018-12-10

Review 9.  The role of general nuclear medicine in breast cancer.

Authors:  Lacey R Greene; Deborah Wilkinson
Journal:  J Med Radiat Sci       Date:  2015-02-12

10.  MYLK and PTGS1 Genetic Variations Associated with Osteoporosis and Benign Breast Tumors in Korean Women.

Authors:  Hye-Won Cho; Hyun-Seok Jin; Yong-Bin Eom
Journal:  Genes (Basel)       Date:  2021-03-06       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.